The Oxford University-AstraZeneca vaccine was first approved by the United Kingdom in December. The clinical trials of the vaccines showed the dosage to be safe and effective at preventing symptomatic Covid-19, with no severe cases and no hospitalisations more than 14 days after the second dose.